Lecap Asset Management LTD Exelixis, Inc. Transaction History
Lecap Asset Management LTD
- $283 Billion
- Q2 2025
A detailed history of Lecap Asset Management LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 9,397 shares of EXEL stock, worth $368,456. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,397
Previous 19,051
50.67%
Holding current value
$368,456
Previous $703 Million
41.12%
% of portfolio
0.15%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding EXEL
# of Institutions
689Shares Held
259MCall Options Held
1.41MPut Options Held
1.55M-
Black Rock Inc. New York, NY33.5MShares$1.31 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$629 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$620 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$446 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...